Fig. 2

Expression analysis of CX3CL1 in AS patients. A expression levels of CX3CL1 in peripheral blood of AS and NC groups; B expression levels of CX3CL1 in PBMC of AS and NC groups; C expression levels of CX3CL1 in intestinal tissue of NC and AS groups; D co-localization of CX3CL1 and iNOS detected by immunofluorescence; E quantitative analysis of iNOS expression detected by immunofluorescence; F correlation analysis of CX3CL1 and iNOS; G–J correlation analysis of CX3CL1 expression in AS patients with TNF-α, IL-6, CRP, and ESR expression. n = 3, data are represented as mean ± SD, ^∗p < 0.05 vs. Control, ^∗∗p < 0.01 vs. Control, ^∗∗*p < 0.001 vs. Control